Advertisement
Advertisement
CHE
Chemed Corporation
548.94
USDSponsored
-0.51
-0.09%
Nov 17, 12:10 UTC -5
Open
Chemed Corporation (CHE) Earnings
CHE Earnings Reports
Positive Surprise Ratio
CHE beat 29 of 43 last estimates.
67%
Next Report
Date of Next Report
Feb 23, 2027
Estimate for Q4 26 (Revenue/ EPS)
$719.05M
/$7.42
Implied change from Q3 26 (Revenue/ EPS)
+4.07%
/+9.93%
Implied change from Q4 25 (Revenue/ EPS)
+12.47%
/+15.58%
Chemed Corporation earnings per share and revenue
On Oct 27, 2026, CHE reported earnings of 6.75 USD per share (EPS) for Q3 26, beating the estimate of 6.50 USD, resulting in a 3.84% surprise. Revenue reached 690.94 million, compared to an expected 691.89 million, with a -0.14% difference. The market reacted with a +4.77% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analysts forecast an EPS of 7.42 USD, with revenue projected to reach 719.05 million USD, implying an increase of 9.93% EPS, and increase of 4.07% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

RadNet, Inc. Common Stock
Report Date
Nov 08, 2026 For Q3 26
Estimate
$0.21
Actual
$0.30
Surprise
+40.06%

LifeStance Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+79.10%

Option Care Health, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.49
Actual
$0.49
Surprise
-0.10%

Aveanna Healthcare Holdings Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.21
Actual
$0.23
Surprise
+8.59%

Addus HomeCare Corp.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$1.83
Actual
$1.83
Surprise
-0.06%

Elanco Animal Health Incorporated Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
$0.20
Actual
$0.27
Surprise
+30.37%
Astrana Health Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.47
Actual
$0.26
Surprise
-45.55%

US Physical Therapy Inc
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.77
Actual
$0.80
Surprise
+3.88%

The Pennant Group, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.35
Surprise
-3.93%
FAQ
What were Chemed Corporation's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Chemed Corporation reported EPS of $6.75, beating estimates by 3.84%, and revenue of $690.94M, -0.14% below expectations.
How did the market react to Chemed Corporation's Q3 2026 earnings?
The stock price moved up 4.77%, changed from $509.09 before the earnings release to $533.36 the day after.
When is Chemed Corporation expected to report next?
The next earning report is scheduled for Feb 23, 2027.
What are the forecasts for Chemed Corporation's next earnings report?
Based on 3
analysts, Chemed Corporation is expected to report EPS of $7.42 and revenue of $719.05M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.